[Inhibition of adrenocortical steroid production in therapy].
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000037:antagonists & inhibitors; D000310:Adrenal Gland Neoplasms / Q000188:drug therapy; D000311:Adrenal Glands / Q000187:drug effects*; D000308:Adrenocortical Hyperfunction / Q000188:drug therapy*; D000616:Aminoglutethimide / Q000494:pharmacology; D000814:Aniline Compounds / Q000494:pharmacology*; D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology; D000927:Anticonvulsants / Q000494:pharmacology*; D003348:Cortisone; D003632:Dichlorodiphenyldichloroethane / Q000494:pharmacology*; D006496:Heparinoids / Q000494:pharmacology; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists; D011728:Pyridones; D011744:Pyrimidinones / Q000494:pharmacology*; D051381:Rats
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000814:Aniline Compounds; D000924:Anticholesteremic Agents; D000927:Anticonvulsants; D006496:Heparinoids; D000451:Mineralocorticoid Receptor Antagonists; D011728:Pyridones; D011744:Pyrimidinones; D000616:Aminoglutethimide; D003632:Dichlorodiphenyldichloroethane; D003348:Cortisone
L'inhibition de la stéroidogénèse cortico-surrénale en thérapeutique.